We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+14.85%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$53.3B
AUM Growth
+$4.24B
Cap. Flow
-$1.7B
Cap. Flow %
-3.2%
Top 10 Hldgs %
12.58%
Holding
3,055
New
851
Increased
757
Reduced
736
Closed
627

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Industrials 8.98%
3 Consumer Discretionary 7.31%
4 Financials 7.07%
5 Healthcare 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
2351
DELISTED
Cantaloupe
CTLP
$103K ﹤0.01%
13,849
-31,671
-70% -$219K
ZETA icon
2352
Zeta Global
ZETA
$7.32B
$101K ﹤0.01%
+11,481
New +$96.3K
FREE
2353
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$101K ﹤0.01%
+29,527
New +$99.7K
DRD
2354
DRDGold
DRD
$2.07B
$98.4K ﹤0.01%
+12,373
New +$106K
BV icon
2355
BrightView Holdings
BV
$1.05B
$98.2K ﹤0.01%
+11,665
New +$88.8K
GTN icon
2356
Gray Television
GTN
$490M
$95.7K ﹤0.01%
10,685
-75,512
-88% -$562K
SPRY icon
2357
ARS Pharmaceuticals
SPRY
$592M
$95.6K ﹤0.01%
+17,439
New +$76.4K
CHPT icon
2358
PUT
ChargePoint
CHPT
$162M
$93.6K ﹤0.01%
2,000
SHCO
2359
DELISTED
Soho House & Co
SHCO
$92.9K ﹤0.01%
+13,053
New +$91.9K
VTNR
2360
DELISTED
Vertex Energy, Inc
VTNR
$92.6K ﹤0.01%
27,310
-105,434
-79% -$414K
TERN
2361
DELISTED
Terns Pharmaceuticals
TERN
$89.9K ﹤0.01%
+13,854
New +$73.2K
ABCL icon
2362
AbCellera Biologics
ABCL
$2.98B
$84.8K ﹤0.01%
+14,853
New +$68.8K
EXK
2363
Endeavour Silver
EXK
$3.14B
$82.1K ﹤0.01%
+41,678
New +$90.6K
LNAI
2364
Lunai Bioworks
LNAI
$10.7M
$81.6K ﹤0.01%
+322
New +$88.2K
OIS icon
2365
Oil States International
OIS
$532M
$80.8K ﹤0.01%
11,895
+1,869
+19% +$13.5K
ABOS icon
2366
Acumen Pharmaceuticals
ABOS
$178M
$79K ﹤0.01%
+20,578
New +$61.1K
XAGEW
2367
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$78.8K ﹤0.01%
342,706
MCRB icon
2368
Seres Therapeutics
MCRB
$47M
$77K ﹤0.01%
+2,751
New +$72.2K
GSAT icon
2369
Globalstar
GSAT
$10.8B
$76.7K ﹤0.01%
+2,634
New +$57.9K
CSTE icon
2370
Caesarstone
CSTE
$104M
$66.9K ﹤0.01%
+17,889
New +$72.2K
GRNT icon
2371
Granite Ridge Resources
GRNT
$683M
$66K ﹤0.01%
10,956
-2,993
-21% -$18.3K
ALDX icon
2372
Aldeyra Therapeutics
ALDX
$91.7M
$65.7K ﹤0.01%
18,720
-48,860
-72% -$151K
BTE icon
2373
Baytex Energy
BTE
$3.08B
$64K ﹤0.01%
19,275
-892,507
-98% -$3.46M
AMWL icon
2374
American Well
AMWL
$222M
$59.8K ﹤0.01%
2,008
-48,740
-96% -$1.2M
PHYT.WS
2375
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$57.7K ﹤0.01%
721,193

Similar funds

Balyasny Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Balyasny Asset Management held 3,055 positions worth $53.3B, up 8.7% from $49B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Balyasny Asset Management withdrew a net $1.7B in Q4 2023, closing 627 positions and reducing 736 holdings. Its most notable exit was Activision Blizzard, an estimated $626M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, down from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Invesco S&P 500 Equal Weight ETF worth $671M.

  • Balyasny Asset Management's largest Q4 2023 buy was Invesco S&P 500 Equal Weight ETF: 4,254,702 shares worth $671M.
  • Balyasny Asset Management added most to Hess in Q4 2023, an estimated $564M increase.
  • Balyasny Asset Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $473M.
  • Balyasny Asset Management fully exited Activision Blizzard in Q4 2023, selling an estimated $626M.
  • Balyasny Asset Management's ten largest holdings make up 13% of its $53.3B portfolio in Q4 2023.
  • Balyasny Asset Management opened 851 new positions and closed 627 in Q4 2023.
  • Balyasny Asset Management's portfolio value rose 8.7% quarter-over-quarter to $53.3B.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.